Tenax Therapeutics
TENX | NASDAQ
$1.48
-$0.14 (-8.64%)
At close: Nov 16, 2026, 4:00 PM ET
$1.48
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-8.64%
(1D)Rating
36
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #635/1021 (Top 62%)
Key Statistics
Market Data
Market Cap $79.11M
1D Range
1.46 1.61
52W Range
1.36 18.32
Valuation (TTM)
PE -1.06
PB 0.73
EV/EBITDA 0.69
Valuation (NTM)
Forward PE N/A
Forward PEG -0.94
Price Target $4.00
Cash Flow
FCF Yield -62.4%
SBC Adj. FCF Yield -52.0%
SBC Impact -16.6%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 118.1% |
90.7%
FCF 3Y | 5Y -63.1% |
-43.2%
Returns
ROA -56.2%
ROE -60.6%
ROIC -64.0%
Financial Health
Net Cash
$113.73M
Current Ratio 14.01
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Tenax Therapeutics, Inc. is a specialized pharmaceutical enterprise dedicated to discovering, advancing, and bringing to market therapies for cardiovascular and pulmonary conditions throughout the Uni...
Sector Healthcare
Industry Biotechnology
Employees 15
IPO Date Apr 4, 1994
Website www.tenaxthera.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
7
Consensus
Hold
Price Target
$4.00
Upside
+170.27%
Buy (3)
Hold (4)
Sell (0)
Add to Watchlist
Select watchlists to add or remove TENX